Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma

Wenwen Cheng, Silvia Gaggero, Lama Hasan Bou Issa, Aïcha Ouelkdite, Guillaume Escure, Adeline Cozzani, Yanick Njosse Tchantchou, Noémie Carlier, Emilie Wauquier, Gauthier Decool, Rémi Tilmont, Benjamin Podvin, Malo Leprohon, Mojtaba Shekarkar, Léa Fléchon, Angélina Kasprowicz, Sophie Groux-Degroote, Jérôme Moreaux, Bertrand Arnulf, Jill Corre, Céline Villenet, Ludovic Martinet, Xavier Leleu, Martin Figeac, Thierry Facon, Wenfei Jin, Suman Mitra, Salomon Manier

Open source

DOI
10.1186/s40364-026-00992-2
Published
2026-09-05
Container
Biomarker Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40364-026-00992-2,
  title = {Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma},
  author = {Wenwen Cheng and Silvia Gaggero and Lama Hasan Bou Issa and Aïcha Ouelkdite and Guillaume Escure and Adeline Cozzani and Yanick Njosse Tchantchou and Noémie Carlier and Emilie Wauquier and Gauthier Decool and Rémi Tilmont and Benjamin Podvin and Malo Leprohon and Mojtaba Shekarkar and Léa Fléchon and Angélina Kasprowicz and Sophie Groux-Degroote and Jérôme Moreaux and Bertrand Arnulf and Jill Corre and Céline Villenet and Ludovic Martinet and Xavier Leleu and Martin Figeac and Thierry Facon and Wenfei Jin and Suman Mitra and Salomon Manier},
  year = {2026},
  journal = {Biomarker Research},
  doi = {10.1186/s40364-026-00992-2},
  url = {https://doi.org/10.1186/s40364-026-00992-2}
}

RIS

TY  - JOUR
TI  - Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma
AU  - Wenwen Cheng
AU  - Silvia Gaggero
AU  - Lama Hasan Bou Issa
AU  - Aïcha Ouelkdite
AU  - Guillaume Escure
AU  - Adeline Cozzani
AU  - Yanick Njosse Tchantchou
AU  - Noémie Carlier
AU  - Emilie Wauquier
AU  - Gauthier Decool
AU  - Rémi Tilmont
AU  - Benjamin Podvin
AU  - Malo Leprohon
AU  - Mojtaba Shekarkar
AU  - Léa Fléchon
AU  - Angélina Kasprowicz
AU  - Sophie Groux-Degroote
AU  - Jérôme Moreaux
AU  - Bertrand Arnulf
AU  - Jill Corre
AU  - Céline Villenet
AU  - Ludovic Martinet
AU  - Xavier Leleu
AU  - Martin Figeac
AU  - Thierry Facon
AU  - Wenfei Jin
AU  - Suman Mitra
AU  - Salomon Manier
PY  - 2026
JO  - Biomarker Research
DO  - 10.1186/s40364-026-00992-2
UR  - https://doi.org/10.1186/s40364-026-00992-2
ER  - 

APA

Cheng, W., Gaggero, S., Issa, L. H. B., Ouelkdite, A., Escure, G., Cozzani, A., Tchantchou, Y. N., Carlier, N., Wauquier, E., Decool, G., Tilmont, R., Podvin, B., Leprohon, M., Shekarkar, M., Fléchon, L., Kasprowicz, A., Groux-Degroote, S., Moreaux, J., Arnulf, B., Corre, J., Villenet, C., Martinet, L., Leleu, X., Figeac, M., Facon, T., Jin, W., Mitra, S., & Manier, S. (2026). Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma. Biomarker Research. https://doi.org/10.1186/s40364-026-00992-2

Source records